Pharma Mar, S.A.

PHMMF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$12$1$44$95
Dep. & Amort.$7$6$6$6
Deferred Tax$0$0$0-$17
Stock-Based Comp.$0$0$0$0
Change in WC-$32-$35-$28-$61
Other Non-Cash$19$14$16$3
Operating Cash Flow$6-$13$38$26
Investing Activities
PP&E Inv.-$15-$16-$9-$8
Net Acquisitions$0$0$0$0
Inv. Purchases-$351-$314-$219$0
Inv. Sales/Matur.$367$287$239$26
Other Inv. Act.$0$0$0$0
Investing Cash Flow$1-$43$11$18
Financing Activities
Debt Repay.$9-$1-$9-$9
Stock Issued$19$19$57$34
Stock Repurch.-$19-$38-$50-$41
Dividends Paid-$11-$12-$12-$11
Other Fin. Act.-$3$0$0$0
Financing Cash Flow-$5-$32-$13-$27
Forex Effect$2-$1$1$0
Net Chg. in Cash$3-$90$36$17
Supplemental Information
Beg. Cash$60$150$113$96
End Cash$63$60$150$113
Free Cash Flow-$9-$29$29$18